Author response to: Reducing dexamethasone premedication with paclitaxel

Author response to: Reducing dexamethasone premedication with paclitaxel

Bibliographic Details
Main Authors:	Vanita Noronha, Deborah Enting, Ravi Thippeswamy, Amit Joshi, Vijay Maruti Patil, Kumar Prabhash
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Cancer Research, Statistics, and Treatment
Online Access:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=128;epage=128;aulast=Noronha

Similar Items

Hypersensitivity reactions to paclitaxel with a modified dexamethasone intravenous premedication regimen
by: Vanita Noronha, et al.
Published: (2018-01-01)

Reducing dexamethasone premedication with paclitaxel
by: Nirmal Vivek Raut
Published: (2019-01-01)

Authors' response to Vora and Rajpurohit
by: Vanita Noronha, et al.
Published: (2020-01-01)

Modified dose dexamethasone premedication for paclitaxel use
by: Sharada Mailankody
Published: (2018-01-01)

Author Reply to: Sahoo, Batra et al. and Mullapally et al.
by: Akhil Rajendra, et al.
Published: (2019-01-01)

Authors' reply to Kumar et al. and Kannan et al.
by: Vijai Simha, et al.
Published: (2020-01-01)

Authors' reply to Daddi
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
by: Vanita Noronha, et al.
Published: (2016-08-01)

Oral metronomic therapy in head and neck cancer – Authors' reply
by: Vijay Patil, et al.
Published: (2021-01-01)

Authors' reply to Chandrasekharan et al. and Abbas
by: Akhil Kapoor, et al.
Published: (2020-01-01)

Authors' reply to Dhanushkodi et al. and Chalissery
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Author Reply to Kapoor et al.
by: Lakhan Kashyap, et al.
Published: (2019-01-01)

Epidermal growth factor receptor-mutated non-small-cell lung cancer: A primer on contemporary management
by: Akhil Rajendra, et al.
Published: (2019-01-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer
by: Vanita Noronha, et al.
Published: (2012-01-01)

Authors' reply to Devaraja, Chaudhuri, and Gupta
by: Vijay M Patil, et al.
Published: (2022-01-01)

Authors' reply to Kulkarni et al. and Wiwanitkit
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)

Leptomeningeal metastasis from extracranial solid tumors
by: Dilip Harindran Vallathol, et al.
Published: (2020-01-01)

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
by: Vikas T. Talreja, et al.
Published: (2020-01-01)

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
by: Vanita Noronha, et al.
Published: (2017-01-01)

Survey for geriatric assessment in practicing oncologists in India
by: Vanita Noronha, et al.
Published: (2019-01-01)

Role of palliative chemotherapy and targeted therapy in advanced esophageal and gastroesophageal junction cancers
by: Vijai Simha, et al.
Published: (2019-01-01)

Evolving role of immunotherapy in head-and-neck cancers: A systemic review
by: Raajit Chanana, et al.
Published: (2018-01-01)

Synchronous primary of periampullary and lung cancer: A case report and review of literature
by: Vikas Talreja, et al.
Published: (2018-01-01)

Systemic treatment options in bladder cancer
by: Rahul Ravind, et al.
Published: (2018-01-01)

Pleural mass imaging - A quick primer
by: Raajit Chanana, et al.
Published: (2018-01-01)

Cytomegalovirus infection in solid malignancies
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
by: Vikas T Talreja, et al.
Published: (2019-01-01)

Authors' reply to Maskomani
by: Minit Shah, et al.
Published: (2023-01-01)

Comparison of the Premedication Effect of Propofol and Dexamethasone on Reducing Fentanyl-Induced Cough
by: Reihanak Talakoub, et al.
Published: (2018-05-01)

Desperate times, desperate measures: Low-dose nivolumab-induced remission in relapsed NSCLC
by: Vikas T Talreja, et al.
Published: (2019-01-01)

Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
by: Vikas T. Talreja, et al.
Published: (2020-01-01)

Authors' reply to Bhargav and Mayilvaganan
by: Saswata Saha, et al.
Published: (2023-01-01)

Authors' reply to Raja and Suryavanshi
by: Anuradha Chougule, et al.
Published: (2020-01-01)

Authors' reply to Bhattacharya
by: Srigadha Vivek Kumar, et al.
Published: (2023-01-01)

Paclitaxel with Mycidac-C in the second line and beyond in advanced head-and-neck cancer: A retrospective analysis from a tertiary cancer center
by: Rup J Sarma, et al.
Published: (2022-01-01)

Authors' reply to Sansar et al. and Kumar
by: Akhil Kapoor, et al.
Published: (2021-01-01)

Author's reply to Kanesvaran et al. and Vora
by: Vanita Noronha, et al.
Published: (2020-01-01)

Coexistence of epidermal growth factor receptor mutation and anaplastic lymphoma kinase translocation in non-small cell lung cancer: Do we know the treatment sequence?
by: Vikas T Talreja, et al.
Published: (2019-01-01)

Chemoprevention in head and neck cancer
by: Joydeep Ghosh, et al.
Published: (2016-01-01)